Key result
TRPV4-mediated calcium influx regulates TGF-beta-induced cardiac fibroblast differentiation via the MAPK/ERK pathway.
Why the study?
The function of transient receptor potential channels in intracellular calcium signaling and differentiation had not been investigated in human ventricular cardiac fibroblasts.
TRPV4-mediated calcium influx is essential for TGF-β-induced differentiation of human ventricular fibroblasts into myofibroblasts via the MAPK/ERK pathway, highlighting a potential therapeutic target for cardiac fibrosis.
Supports TRPV4 as antifibrotic target in fibroblasts; hypothesis-generating for human cardiac fibrosis.
Background: Cardiac fibroblasts (CFs) are principal extracellular matrix-producing cells. In response to injury, CFs transdifferentiate into myofibroblasts. Intracellular calcium (Ca 2+ ) signaling, involved in fibroblast proliferation and differentiation, is activated in fibroblasts through transient receptor potential (TRP) channels, but the function of these channels has not been investigated in human ventricular CFs. Under evaluation in this study, was the role of TRP channels in the differentiation of human ventricular CFs induced by transforming the growth factor beta (TGF- β ), a pro-fibrotic cytokine. Methods: Human ventricular CFs were used in this study. The differentiation of CFs into myofibroblast was induced with TGF- β and was identified by the expression of smooth muscle actin. Results: Results indicate that Ca 2+ signaling was an essential component of ventricular CF differentiation. CFs treated with TGF- β demonstrated increased expression of a TRP channel, TRPV4, both at the mRNA and protein levels, which corresponded with CF-myofibroblast trans-differentiation, as evidenced by the upregulation of α -smooth muscle actin, a myofibroblast marker, and plasminogen activator inhibitor-1, which are fibrogenesis markers. An agonist of TRPV4 induced the conversion of CFs into myofibroblasts, whereas it’s antagonist as well a Ca 2+ chelating agent reduced it, indicating that the Ca 2+ influx throughTRPV4 is required for CF trans-differentiation. Overall, these results demonstrate that TRPV4-mediated Ca 2+ influx participates in regulating the differentiation of human ventricular CFs into myofibroblasts through the MAPK/ERK pathway. Conclusions: Overall, these results demonstrate that TRPV4-mediated Ca 2+ influx participates in regulating the differentiation of human ventricular CFs into myofibroblasts through the MAPK/ERK pathway.
No takes yet. Share an insight, caveat, or question.
Ahn et al. (2020) studied Cardiac fibrosis (in vitro). TRPV4 agonist (GSK1016790A) and antagonist (RN-9893) vs. Vehicle control was evaluated on Expression of α-smooth muscle actin (α-SMA) and PAI-1 (p=<0.05). TRPV4-mediated calcium influx regulates the transforming growth factor beta-induced differentiation of human ventricular cardiac fibroblasts into myofibroblasts through the MAPK/ERK pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: